A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Single Dose of the Lyophilized Formulation of Merck Staphylococcus aureus Vaccine (V710) in Healthy Adults.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Single Dose of the Lyophilized Formulation of Merck Staphylococcus aureus Vaccine (V710) in Healthy Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Nov 2014

At a glance

  • Drugs V-710 (Primary)
  • Indications Staphylococcal infections
  • Focus Pharmacodynamics
  • Sponsors Merck & Co; Merck Sharp & Dohme
  • Most Recent Events

    • 19 Dec 2011 Results published in Vaccine.
    • 18 Nov 2011 Additional location (USA) added as reported by ClinicalTrials.gov.
    • 22 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top